GB1007758A - í¸-3:19-dioxo-steroids and í¸-3-oxo-steroid-19-acids - Google Patents
í¸-3:19-dioxo-steroids and í¸-3-oxo-steroid-19-acidsInfo
- Publication number
- GB1007758A GB1007758A GB1091764A GB1091764A GB1007758A GB 1007758 A GB1007758 A GB 1007758A GB 1091764 A GB1091764 A GB 1091764A GB 1091764 A GB1091764 A GB 1091764A GB 1007758 A GB1007758 A GB 1007758A
- Authority
- GB
- United Kingdom
- Prior art keywords
- oxo
- hydroxy
- dioxo
- compounds
- pregnane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Abstract
The invention comprises D 4,6-3,19-dioxo-steroids and D 4,6-3-oxo-steroid-19-acids of the androstane and 20-keto-pregnane series, the preparation of the dioxo compounds of any steroid series by oxidation of D 4,6-3-oxo-19-hydroxy-steroids with chromium trioxide in pyridine, and the preparation of the 3-oxo-19-acid of any steroid series by oxidation of the 19-hydroxy or 19-oxo compounds with a compound of hexavalent chromium in the presence of a strong acid. The steroids, e.g. of the androstane, pregnane cholane cholestane, spirostane or cardanolide series, may contain free, ketalized or enolized oxo groups, free, esterified or etherified hydroxyl groups, alkyl groups and/or halogen atoms as substituents in the ring or 17-side chain, and they may also contain additional double bonds and oxido groups. Particularly mentioned are 17-oxo, 17b -hydroxy and 17b -hydroxy - 17a -(alkyl, alkenyl or alkyenyl)-androstane compounds and 20-oxo pregnane compounds which may contain 17a -hydroxy, 21-hydroxy, 6- and 16-methyl, 6-halo and 16,17-oxido substituents and D 16-double bonds; and esters of these compounds with a wide variety of organic carboxylic and carbonic acids; and 17-ethers. Examples are given. D 4,6 - 3,20 - dioxo - 17a - caproyloxy - 19 - hydroxy - pregnadiene is prepared by reacting D 4 - 3,20 - dioxo - 17a - caproyloxy - 6b ,19-oxido-pregnane with acetic anhydride and p-toluene-sulphonic acid, followed by partial hydrolysis of the 19-acetate. Specifications 994,746, 994,748 and 1,007,756 are referred to.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH827061A CH425774A (en) | 1961-07-14 | 1961-07-14 | Process for the production of 19-nor-steroids |
CH1517161A CH428718A (en) | 1961-12-29 | 1961-12-29 | Process for the production of halogen steroids |
CH1516961A CH487135A (en) | 1961-07-14 | 1961-12-29 | Process for the production of 19-nor-steroids |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1007758A true GB1007758A (en) | 1965-10-22 |
Family
ID=27175968
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2672162A Expired GB1007757A (en) | 1961-07-14 | 1962-07-11 | 19-nor-steroids and process for their manufacture |
GB1091764A Expired GB1007758A (en) | 1961-07-14 | 1962-07-11 | í¸-3:19-dioxo-steroids and í¸-3-oxo-steroid-19-acids |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2672162A Expired GB1007757A (en) | 1961-07-14 | 1962-07-11 | 19-nor-steroids and process for their manufacture |
Country Status (2)
Country | Link |
---|---|
FR (2) | FR6461M (en) |
GB (2) | GB1007757A (en) |
-
1962
- 1962-07-11 GB GB2672162A patent/GB1007757A/en not_active Expired
- 1962-07-11 GB GB1091764A patent/GB1007758A/en not_active Expired
- 1962-10-12 FR FR912034A patent/FR6461M/fr not_active Expired
- 1962-10-12 FR FR912035A patent/FR6462M/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FR6462M (en) | 1968-11-18 |
FR6461M (en) | 1968-11-18 |
GB1007757A (en) | 1965-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1007758A (en) | í¸-3:19-dioxo-steroids and í¸-3-oxo-steroid-19-acids | |
GB1037891A (en) | Process for the manufacture of 19-nor-steroids | |
GB780301A (en) | Manufacture of steroids with oxygen in 11-position | |
GB892620A (en) | Cyclopentanophenanthrene derivatives | |
GB1008274A (en) | Process for the manufacture of steroid-dienes | |
GB994748A (en) | Process for the manufacture of new oxido-steroids | |
ES319114A1 (en) | A procedure for preparing the 21-hydroxy steroids of the pregnan series esterified in the position 21. (Machine-translation by Google Translate, not legally binding) | |
GB1377993A (en) | 6alpha, 16alpha-dimethyl-steroids | |
GB957436A (en) | 16ª‡-halomethyl-derivatives of steroids of the 17ª‡-hydroxy-pregnane series and a process for their manufacture | |
GB1011573A (en) | Process for the manufacture of 19-nor-steroids | |
GB792223A (en) | Synthesis of steroids | |
GB843108A (en) | Process for the preparation of cyclopentanophenanthrene derivatives | |
GB855800A (en) | New cyclopentanophenanthrene derivatives and process for the production thereof | |
GB1029438A (en) | Process for preparing 6-keto-í¸-19-nor-3-acyloxy steroids | |
GB1164647A (en) | 2,2-Spiro-Pyrazolinyl-Steroids | |
GB777996A (en) | Steriod compounds and their preparation | |
GB924588A (en) | Improvements in or relating to a - nor - steroid derivatives | |
GB982922A (en) | New í¸-11ª‡-hydroxy-steroids and process for their manufacture | |
GB994749A (en) | 19-oxygenated and 19-nor-steroids and process for their manufacture | |
GB729595A (en) | Manufacture of compounds of the steroid series | |
GB843353A (en) | Improvements in or relating to 6-methyl steroid compounds | |
GB941695A (en) | ||
GB1022209A (en) | Cyclosteriods and process for their manufacture | |
GB1008271A (en) | Process for the manufacture of 19-nor-steroids | |
GB1065386A (en) | Improvements in or relating to 3-desoxy-steroids |